The relationship between inflammation and new bone formation in patients with ankylosing spondylitis

被引:191
作者
Baraliakos, Xenofon [1 ]
Listing, Joachim [2 ]
Rudwaleit, Martin [3 ]
Sieper, Joachim [3 ]
Braun, Juergen [1 ]
机构
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, D-44652 Herne, Germany
[2] German Rheumatism Res Ctr, D-10117 Berlin, Germany
[3] Charite, D-12200 Berlin, Germany
关键词
D O I
10.1186/ar2496
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Spinal inflammation as detected by magnetic resonance imaging and new bone formation as identified by conventional radiographs are characteristic of ankylosing spondylitis. Whether and how spondylitis and syndesmophyte formation are linked are unclear. Our objective was to investigate whether and how spinal inflammation are associated with new bone formation in ankylosing spondylitis. Methods Spinal magnetic resonance images and conventional radiographs from 39 ankylosing spondylitis patients treated with anti-tumour necrosis factor (anti-TNF) agents at baseline and after 2 years were analysed for syndesmophyte formation at vertebral edges with or without inflammatory lesions at baseline. Results Overall, 922 vertebral edges at the cervical and lumbar spine were analysed. At baseline, the proportion of vertebral edges with and without inflammation (magnetic resonance imaging) that showed structural changes (conventional radiographs) was similar (in total, 16.6% of all vertebral edges in 71.4% of patients). From the perspective of syndesmophyte formation (n = 26, 2.9%) after 2 years, there were more vertebral edges without (62%) than with (38%) inflammation at baseline (P = 0.03). From the perspective of spinal inflammation at baseline (n = 153 vertebral edges), more syndesmophytes developed at vertebral edges with (6.5%) than without (2.1%) inflammation (P = 0.002, odds ratio 3.3, 95% confidence interval 1.5 to 7.4). Inflammation persisted in 31% of the initially inflamed vertebral edges (n = 132), and new lesions developed in 8% of the vertebral edges without inflammation at baseline (n = 410). From the perspective of spinal inflammation after 2 years (n = 72 vertebral edges), 5.6% of the vertebral edges showed syndesmophyte development in contrast to 1.9% of the vertebral edges with new syndesmophytes without inflammation (P = 0.06). Conclusions These findings obtained in patients treated with anti-TNF agents suggest linkage and some dissociation of inflammation and new bone formation in ankylosing spondylitis. Although syndesmophytes were also found to develop at sites where no inflammation had been seen by magnetic resonance imaging at baseline, it was more likely that syndesmophytes developed in inflamed vertebral edges. More effective suppression of spinal inflammation may be required to inhibit structural damage in ankylosing spondylitis.
引用
收藏
页数:7
相关论文
共 46 条
[1]   Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α [J].
Allali, F ;
Breban, M ;
Porcher, R ;
Maillefert, JF ;
Dougados, M ;
Roux, C .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) :347-349
[2]   Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis [J].
Appel, Heiner ;
Loddenkemper, Christoph ;
Grozdanovic, Zarko ;
Ebhardt, Harald ;
Dreimann, Marc ;
Hempfing, Axel ;
Stein, Harald ;
Metz-Stavenhagen, Peter ;
Rudwaleit, Martin ;
Sieper, Joachim .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (05)
[3]   Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab [J].
Baraliakos, X. ;
Listing, J. ;
Brandt, J. ;
Haibel, H. ;
Rudwaleit, M. ;
Sieper, J. ;
Braun, J. .
RHEUMATOLOGY, 2007, 46 (09) :1450-1453
[4]   Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes [J].
Baraliakos, X. ;
Listing, J. ;
Rudwaleit, M. ;
Haibel, H. ;
Brandt, J. ;
Sieper, J. ;
Braun, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) :910-915
[5]   Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept:: Clinical and magnetic resonance imaging data [J].
Baraliakos, X ;
Brandt, J ;
Listing, J ;
Haibel, H ;
Sörensen, H ;
Rudwaleit, M ;
Sieper, J ;
Braun, J .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :856-863
[6]   Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor a antibody infliximab [J].
Baraliakos, X ;
Listing, J ;
Rudwaleit, M ;
Brandt, J ;
Sieper, J ;
Braun, J .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1462-1466
[7]   Magnetic resonance imaging examinations of the spine in patients with Ankylosing spondylitis before and after therapy with the tumor necrosis factor α receptor fusion protein etanercept [J].
Baraliakos, X ;
Davis, J ;
Tsuji, W ;
Braun, J .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1216-1223
[8]   Inflammation in ankylosing spondylitis:: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging [J].
Baraliakos, X ;
Landewé, R ;
Hermann, KG ;
Listing, J ;
Golder, W ;
Brandt, J ;
Rudwaleit, M ;
Bollow, M ;
Sieper, J ;
van der Heijde, D ;
Braun, J .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) :730-734
[9]   Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging:: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences [J].
Baraliakos, X ;
Hermann, KGA ;
Landewé, R ;
Listing, J ;
Golder, W ;
Brandt, J ;
Rudwaleit, M ;
Bollow, M ;
Sieper, J ;
van der Heijde, D ;
Braun, J .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1141-1144
[10]  
BARALIAKOS X, 2007, ANN SCI M AM COLL RH